Keyphrases
University of Minnesota
100%
Sarcoidosis
100%
Clinical Characteristics
100%
Organ System
100%
Characteristic System
100%
System Involvement
100%
High Variability
20%
Obstructive Pattern
20%
Minnesota
10%
Liver
10%
High Risk
10%
Clinical Presentation
10%
Clinical Management
10%
Disease Course
10%
Clinical Disease
10%
Disease Outcome
10%
Serum Biomarkers
10%
Alpha-1 Antitrypsin Deficiency
10%
Retrospective Analysis
10%
Anti-inflammatory Therapy
10%
Disease Severity
10%
Tertiary Care Hospital
10%
Pulmonary Function Test
10%
People of Color
10%
Genomic Research
10%
Spleen
10%
Angiotensin-converting Enzyme
10%
Cardiac Disease
10%
Assessment Instrument
10%
Soluble interleukin-2 Receptor (sIL-2R)
10%
Biopsy-proven
10%
Age at Diagnosis
10%
Multisystem Disease
10%
Clinical Phenotype
10%
Unknown Etiology
10%
Laboratory Parameters
10%
Stage II-III
10%
Organ Involvement
10%
Racial Distribution
10%
Physiological Patterns
10%
Presentation Course
10%
Clinical Cohort Study
10%
Disease Activity Marker
10%
Restrictive Pattern
10%
Multiorgan Disease
10%
Organ Assessment
10%
Systemic Granulomatous Disease
10%
Cohort Features
10%
Sarcoidosis Activity
10%
Scadding Stage
10%
Retrospective Data Collection
10%
Thoracic Lymph Nodes
10%
Biochemistry, Genetics and Molecular Biology
Angiotensin-Converting Enzyme
100%
Cohort Study
100%
Lung Function
100%
Interleukin 2
100%
Alpha 1-Antitrypsin
100%
Genomics
100%
Medicine and Dentistry
Sarcoidosis
100%
Organ Systems
100%
Biological Marker
18%
Cohort Analysis
9%
Multiple Organ Dysfunction Syndrome
9%
Disease Course
9%
Clinical Management
9%
Heart Disease
9%
Alpha 1-Antitrypsin Deficiency
9%
Anti-Inflammatory Drug
9%
Systemic Disease
9%
Disease Severity
9%
Dipeptidyl Carboxypeptidase
9%
Biopsy Technique
9%
Disease Activity
9%
Granulomatosis
9%
Lung Function Test
9%
Soluble Interleukin 2 Receptor
9%
Thoracic Lymph Nodes
9%
Immunology and Microbiology
Organ Systems
100%
Sarcoidosis
100%
Interleukin 2 Receptor
9%
Lung Function
9%
Lymph Node
9%
Alpha 1-Antitrypsin
9%